Krystal Biotech (KRYS) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Krystal Biotech Revenue Highlights


Latest Revenue (Y)

$50.70M

Latest Revenue (Q)

$70.28M

Krystal Biotech Revenue by Period


Krystal Biotech Revenue by Year

DateRevenueChange
2023-12-31$50.70M100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--100.00%
2018-12-31$1.03M100.00%
2017-12-31-100.00%
2016-12-31--

Krystal Biotech generated $50.70M in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 4936.61% compared to the same period a year ago.

Krystal Biotech Revenue by Quarter

DateRevenueChange
2024-06-30$70.28M55.32%
2024-03-31$45.25M7.37%
2023-12-31$42.14M392.55%
2023-09-30$8.56M100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30--100.00%
2019-06-30$542.00K-7.03%
2019-03-31$583.00K-43.23%
2018-12-31$1.03M373.27%
2018-09-30$217.00K25.43%
2018-06-30$173.00K36.22%
2018-03-31$127.00K100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30--

Krystal Biotech generated $70.28M in revenue during Q1 2024, up 55.32% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Krystal Biotech Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
APLSApellis Pharmaceuticals$366.28M$179.14M
DCPHDeciphera Pharmaceuticals$163.36M$45.00M
RGNXREGENXBIO$90.24M$22.30M
RYTMRhythm Pharmaceuticals$77.43M$25.97M
KRYSKrystal Biotech$50.70M$70.28M
MGTXMeiraGTx$14.02M$282.00K

KRYS Revenue FAQ


Krystal Biotech's yearly revenue for 2023 was $50.7M, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. KRYS's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

Krystal Biotech's quarterly revenue for Q1 2024 was $70.28M, a 55.32% increase from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $45.25M, a 7.37% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). KRYS's quarterly revenue for Q3 2023 was $42.14M, a 392.55% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).

Krystal Biotech's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.